Delivery Order SPE2DB24D1007-SPE2DB25FBZHG

Award Date 11/15/24
Potential Completion Date 11/18/24
Potential Value $2.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of Eliquis 2.5 mg tablets. The $7,862.40 firm-fixed-price contract has a completion date of January 10, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical...
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $2,020.77 firm fixed-price delivery order is for the supply of Eliquis 2.5 mg tablets. The contract has an ultimate completion date of July 10, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,965.60 firm fixed-price delivery order is for the supply of Eliquis 2.5 mg tablets. The contract has a performance period through May 9, 2025 and is not set aside for any specific business category. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, provides for the delivery of Eliquis 5 mg tablets to the Defense Logistics Agency (DLA) for a ceiling value of $10,578.53. The contract is a delivery order with a firm fixed price, and the ultimate completion date is June 13, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, which serves...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Eliquis 5 mg tablets. The single-award contract has a ceiling value of $4,287.52 and a period of performance through January 24, 2025. The contract is a firm fixed-price Delivery Order with no set-aside designation, indicating open competition. Amerisourcebergen holds a separate $999,999,999 Indefinite Delivery Contract (IDC) with...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Eliquis 5 mg tablets. The contract has a ceiling value of $29,480.21 and is a firm fixed price contract with a completion date of September 19, 2024. The contract is not set aside for any specific socioeconomic program. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,895.39 firm fixed-price delivery order is for the supply of Eliquis 5 mg tablets. The contract has an ultimate completion date of February 3, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Eliquis 2.5 mg tablets. The fixed-price delivery order, valued at $1,900.08, has a completion date of June 6, 2024. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range of pharmaceutical products...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $5,357.42 Firm Fixed Price delivery order is for the supply of Eliquis 2.5 mg tablet (60s) to support military healthcare programs. The contract has an ultimate completion date of September 6, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for the delivery of Eliquis 2.5 mg tablets. The contract has a ceiling value of $7,250.33 and an ultimate completion date of December 9, 2022. The contract is a Delivery Order under a Firm Fixed Price arrangement, with no set-aside designation indicated. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
  • SPE2DB24D1007
    Indefinite Delivery Contract
  • SPE2DB24D1007-SPE2DB25FBZHG
    Delivery Order

This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is for the delivery of Eliquis 2.5 mg tablets. The contract has a ceiling value of $2,375.10 and an ultimate completion date of November 18, 2024. It is a firm fixed-price delivery order contract, with no set-aside designation.

Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The current contract award is likely a task order issued under this larger IDC framework.

Generated 5/20/25, 2:03 PM